Defining the appropriate starting dose of lenalidomide in chronic lymphocytic leukemia: remember the old fable of the hare and the tortoise

Leuk Lymphoma. 2016;57(6):1247-8. doi: 10.3109/10428194.2015.1137294. Epub 2016 Feb 17.

Authors

Constantine S Tam^{1

2}, Aaron Polliack³

Affiliations

¹ a Department of Haematology , Peter MacCallum Cancer Centre , Melbourne , Victoria , Australia ;
² b Department of Medicine, University of Melbourne , Melbourne , Victoria , Australia ;
³ c Department of Hematology , Hadassah University Hospital and Hebrew University Medical School , Jerusalem , Israel.

PMID: 26732524
DOI: 10.3109/10428194.2015.1137294

No abstract available

Publication types

Comment

MeSH terms

Animals
Antineoplastic Agents / therapeutic use
Hares*
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*

Substances

Antineoplastic Agents